Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. Get the […]
Alcon
Alcon beats the Street with Q1 results
Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year. The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March […]
18 of the world’s most innovative medical technologies
Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]
Alcon SmartCataract study shows enhanced time savings during cataract surgery
Alcon (NYSE:ALC) announced data from a clinical study supporting the use of its SmartCataract solutions for cataract surgery. Geneva, Switzerland-based Alcon will present the data at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting. According to a news release, Alcon’s latest data for the SmartCataract demonstrates significant time savings delivered during the […]
Alcon launches new dry eye treatment device
Alcon announced that it introduced the Systane iLux meibomian gland dysfunction (MGD) thermal pulsation system. Geneva, Switzerland-based Alcon designed the all-in-one, handheld Systane iLux MGD thermal pulsation device with new imaging technology to capture infrared photos and HD video of the meibomian glands. The system allows patients to see the need for treatment, visualize their […]
Alcon launches Clareon intraocular lens in U.S.
Alcon (SIX/NYSE:ALC) announced today that it launched the Clareon family of intraocular lenses (IOLs) in the U.S. Geneva, Switzerland-based Alcon designed the Clareon family of lenses with a glistening-free IOL material with the lowest levels of haze and subsurface nanoglistenings (SSNGs) compared to leading competitors’ IOLs, according to a news release. The company describes Clareon […]
Alcon stock up on Street-beating Q4
Alcon (SIX/NYSE:ALC) stock is up today after the eye care tech company reported fourth-quarter results that surpassed Wall Street expectations. Geneva, Switzerland–based Alcon yesterday evening reported profits of $139 million, or 28¢ per share, off $2.149 billion in sales for the quarter ended Dec. 31, 2021, for a bottom-line gain of 46% and a top-line […]
Alcon closes Ivantis acquisition
Alcon (NYSE:ALC) announced today that it completed its $475 million acquisition of glaucoma surgery device maker Ivantis. Geneva, Switzerland-based Alcon initially announced the acquisition of Ivantis, which develops the Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device, in November 2021. Get the full story at our sister site, Medical Tubing & Extrusion.
Alcon to acquire Ivantis for $475M
Alcon (NYSE:ALC) announced today that it intends to acquire glaucoma surgery device maker Ivantis for $475 million upfront. Geneva, Switzerland-based Alcon aims to bolster its portfolio across cataract, refractive, retina and glaucoma offerings by acquiring Ivantis and its novel Hydrus Microstent for minimally invasive glaucoma surgery (MIGS). Ivantis designed the Hydrus Microstent to lower intraocular […]
MedTech 100 roundup: On the rise again
After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]
Alcon reports 74% sales growth in Q2, raises 2021 guidance
Alcon (NYSE:ALC) this week posted second-quarter results that beat the overall consensus on Wall Street and raised its full-year guidance. The Geneva-based eye care company reported profits of $151 million, or 31¢ per share, on sales of $2.1 billion for the three months ended June 30, for a sales growth of 74.79% compared with Q2 2020. […]
